004310.KS
Hyundai Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 10,500.00
+5.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 64.48x
- PEG TTM
- 16.28x
- Price / book
- 2.15x
- Price / sales
- 1.36x
- Price / cash flow
- 85.62x
Enterprise value
- Enterprise value
- KRW 306.4B
- EV / sales
- 1.51x
- EV / EBITDA
- 26.78x
- EV / EBIT
- 50.49x
- Market cap
- KRW 275.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026